BioWorld Asia

Sep. 12, 2007

View Archived Issues

Swedish Study Finds Molecular Cause For Kidney Infections

Aptuit Paying $64M For Evotec Chemistry Unit

Antisoma's Lung Cancer Drug Repeats Strong Phase II Results

Biotech Fears Tough Restrictions From EU On Use of Primates

Nanobody Alliance With BI Could Net €200M For Ablynx

No Abstract Read More

FDA OKs TopoTarget's Totect For Extravasation Treatment

Other News To Note

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Business and Academia Merge In UK-Australia Partnership

UK Opens Door to Work With Hybrid Embryos

LONDON - The UK regulator has agreed to the generation of human/animal hybrid embryos for stem cell research, paving the way for it to consider two applications for licenses to conduct such research. (BioWorld International) Read More

MediGene Gets $21M In Private Share Placement

Today's news in brief

BioWorld

BioWorld briefs for June 29, 2026.

Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

ENCALS 2026: From genetics to advancing strategies against ALS

BioWorld Science

Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...

Next wave of BCI firms builds on pioneers to tackle challenges

BioWorld

With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...

Boehringer Ingelheim identifies new mGlu3 receptor agonists

BioWorld Science

Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...

GT-02897 exerts efficacy in preclinical multiple myeloma

BioWorld Science

Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...